A Rare Entity in Multiple Myeloma: Six Nerve Paralysis

Creative Commons License

ÇETİN G., AR M. C., Cerit A., Gozubenli K., Erdem S., Halac G.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, vol.30, 2014 (SCI-Expanded) identifier identifier


Ophthalmic involvement appears rarely in multiple myeloma (MM). Ophthalmic findings are mostly noted as complications caused by disease or treatment. MM-associated with 6th nerve paralysis is a rare entity. Bortezomib, one of the novel agents used to treat MM, has neurotoxic effect and may cause permanent nerve damage. Herein, we report a 50-year-old male patient with MM who developed the 6th nerve paralysis while receiving bortezomib and discuss its relevant causes.